Vol 75, No 3 | The Journal of Clinical Psychiatry

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

J Clin Psychiatry 2014;75(3):205-214

Peiling Yang, PhD; Mitchell Mathis, MD; Thomas P. Laughren, MD; Ni A. Khin, MD; Yeh-Fong Chen, PhD; Silvana Borges, MD; Robert Temple, MD; Hiren D. Patel, PharmD; Paul A. David, RPh; Ellis Unger, MD

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

J Clin Psychiatry 2014;75(3):e184-e190

Sheela Kolluri, PhD; John M. Kane, MD; W. Wolfgang Fleischhacker, MD; Jamie Geier, PhD; Onur Karayal, MD, MPH; Sybil M. Eng, PhD; Robert F. Reynolds, ScD; Brian L. Strom, MD, MPH

Original Research

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

J Clin Psychiatry 2014;75(3):e191-e197

Isabelle Jaussent, PhD; Philippe Courtet, MD, PhD; Enrique Baca-García, MD, PhD; Jorge Lopez-Castroman, MD, PhD; Sebastien Guillaume, MD, PhD; Emilie Olié, MD; Lucas Giner, MD, PhD; Séverine Béziat, MSc

Original Research

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

J Clin Psychiatry 2014;75(3):222-230

Lori A. Zoellner, PhD; Norah C. Feeny, PhD; Quang A. Le, PharmD, PhD; Jason N. Doctor, PhD

Original Research

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

J Clin Psychiatry 2014;75(3):231-237

Nicolas Hoertel, MD; Frédéric Limosin, MD, PhD; Anne-Sophie Seigneurie, MD; Philip Gorwood, MD, PhD; Bruno Falissard, MD, PhD; Keith Humphreys, PhD

Original Research

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

J Clin Psychiatry 2014;75(3):247-253

Carlos Blanco, MD, PhD; Mark Olfson, MD, MPH; Shuai Wang, PhD; Kurt Kroenke, MD

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

J Clin Psychiatry 2014;75(3):254-263

Christian Simhandl, MD, PhD; Barbara König, PhD; Benedikt L. Amann, MD, PhD

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

J Clin Psychiatry 2014;75(3):274-275

Jonathan M. Meyer, MD; Anissa Abi-Dargham, MD

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

J Clin Psychiatry 2014;75(3):e198-e200

Chittaranjan Andrade, MD

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

J Clin Psychiatry 2014;75(3):285-287

Christoph U. Correll, MD; Swapnil Gupta, MBBS, MD; John D. Cahill, MBBS; Mohini Ranganathan, MD

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

J Clin Psychiatry 2014;75(3):288

Matthias W. Riepe, MD, Dipl-Phys

Letter to the Editor

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

J Clin Psychiatry 2014;75(3):289-290

Rex L. Cannon, PhD; H. E. Pigott, PhD; Tanju Surmeli, MD; Deborah R. Simkin, MD; Robert W. Thatcher, PhD; Werner Van den Bergh, MD; Gerald Gluck, PhD; Joel F. Lubar, PhD; Richard Davis, MS; Dale S. Foster, PhD; Jonathan Douglas, PhD; Atholl T. Malcolm, PhD; Donald Bars, PhD; Kirk Little, PsyD; Wes Center, PhD; Marvin Berman, PhD; Harold Russell, PhD; Barbara Hammer, PhD; J. Lucas Koberda, MD, PhD

Letter to the Editor

Dr van Dongen-Boomsma and Colleagues Reply

J Clin Psychiatry 2014;75(3):290

Jan K. Buitelaar, MD, PhD; Martine van Dongen-Boomsma, MD; Madelon A. Vollebregt, MSc; Dorine Slaats-Willemse, PhD

Letter to the Editor

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

J Clin Psychiatry 2014;75(3):290

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

J Clin Psychiatry 2014;75(3):e05

Larry Culpepper, MD, MPH

Educational Activity

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

J Clin Psychiatry 2014;75(3):e06

William G. Ondo, MD

Educational Activity

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

J Clin Psychiatry 2014;75(3):e07

Charles F. Brady, PhD, ABPP

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

J Clin Psychiatry 2014;75(3):e201

Scott Temple, PhD

Volume 75 • 2014 • 3

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

Dr van Dongen-Boomsma and Colleagues Reply

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

ELSEWHERE:

FOLLOW US:

Volume 75 • 2014 • 3

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

Dr van Dongen-Boomsma and Colleagues Reply

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Subscribe to readmore articles

Subscribe to read
more articles